Iodine status in premature newborns

Casopis Lekaru Ceskych
|December 17, 2021
PubMed

Insights

Iodine deficiency is a risk for premature newborns due to developmental factors. This review examines guidelines for iodine intake in preterm infants, considering their unique nutritional needs and risks.

Area of Science:

  • Endocrinology
  • Neonatology
  • Nutritional Science

Background:

  • Iodine is vital for thyroid function, growth, and development.
  • Iodine deficiency persists globally, affecting at-risk populations like premature infants.
  • Preterm newborns face unique risks for iodine deficiency due to immaturity and intake issues.

Purpose of the Study:

  • To review global guidelines for optimal iodine intake in preterm newborns.
  • To analyze current data on iodine content in infant nutrition sources.
  • To address the balance between iodine sufficiency and potential toxicity in neonates.

Main Methods:

  • Systematic review of international clinical guidelines on neonatal iodine intake.
  • Analysis of published data on iodine concentrations in parenteral nutrition, breast milk, and infant formulas.
  • Synthesis of current evidence regarding iodine requirements and risks in preterm infants.

Main Results:

  • Variability exists in global recommendations for preterm infant iodine intake.
  • Iodine content differs significantly across various nutritional support methods.
  • Preterm infants are susceptible to both deficiency and excess iodine exposure.

Conclusions:

  • Optimal iodine management in preterm infants requires careful consideration of individual needs and nutritional sources.
  • Further research is needed to standardize iodine supplementation protocols for vulnerable neonates.
  • Balancing iodine intake is critical for thyroid health and neurodevelopment in premature infants.

Related Concept Videos

Redox Titration: Iodimetry and Iodometry01:23

Redox Titration: Iodimetry and Iodometry

Iodometry and iodimetry are analytical methods used to determine the concentration of oxidizing or reducing agents using iodine. In iodometric titrations, the oxidizing analyte solution is usually acidified and treated with an excess of iodide ions, which generates an equivalent amount of iodine in equilibrium with triiodide. The released iodine is subsequently titrated directly against a standardized reducing agent. As the dilute iodine color becomes pale yellow, a few drops of freshly...
3.1K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
497
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
28
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
24
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
15